NAMI National • Recent Post
Recent announcement by the FDA
Changes Announced for Monitoring Clozapine to Improve Delivery of Treatment, Increase Access
A recent announcement by the FDA stated that beginning October 15 it will change the approach to monitoring clozapine.
As you may know, those taking clozapine, must have their blood drawn on a structured schedule to monitor their neutrophil counts … See more at: